United States · FDA National Drug Code directory
Cholestyramine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51224-011_94d7bc24-2f81-463b-b646-92fbf6641f71
- Product NDC
- 51224-011
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Cholestyramine
- Labeler
- TAGI Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210310 / 20261130
Source-listed ingredients
- CHOLESTYRAMINE — 4 g/8.3g
These values do not establish equivalence or a dose recommendation.
Packages
- 348.6 g in 1 CAN (51224-011-10) · 51224-011-10
- 60 POUCH in 1 CARTON (51224-011-20) / 8.3 g in 1 POUCH · 51224-011-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →